Trial intelligence / Profile preview

Prophylaxis for IOP Spikes after Intravitreal Bevacizumab

NCT00864838Phase 2Completed

Sponsor
Universidade de São Paulo
Start
Jun 2008
Primary completion
Feb 2009
Modality
Small Molecules
01

Overview

A Phase 2 trial of acetazolamide, brimonidine in ocular hypertension, sponsored by Universidade de São Paulo. Started Jun 2008; status: completed.

02

Drugs

acetazolamidebrimonidine
03

Conditions

ocular hypertension

Beyond the preview

Go deeper on NCT00864838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00864838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call